Life Insurance After Skin Cancer: 2027 Underwriting Guide
Life insurance after skin cancer is often available, but the underwriting result depends heavily on the exact diagnosis. A fully treated superficial basal cell carcinoma can be viewed very differently from invasive melanoma. The insurer will care about the pathology report, stage, depth, ulceration, lymph-node involvement, recurrence history, treatment, and time since treatment.
Can You Get Life Insurance After Skin Cancer?
Yes. Many people with a history of basal cell carcinoma or superficial squamous cell carcinoma can qualify for favorable life insurance rates after successful treatment and appropriate follow-up. Melanoma is underwritten more cautiously. Early, completely treated melanoma may still be insurable, while deeper, recurrent, node-positive, metastatic, or recently treated melanoma can lead to higher premiums, a temporary postponement, or a decline. Carrier selection matters.
Complete the risk assessment first so the pathology, treatment history, and carrier underwriting can be compared before an application is submitted.
Table of Contents
How Does the Type of Skin Cancer Affect Life Insurance?
The three diagnoses most consumers mean when they say “skin cancer” are basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma. They do not carry the same mortality risk and should not be treated the same in underwriting.
| Skin Cancer Type | General Underwriting Concern | What Matters Most | Possible Direction |
|---|---|---|---|
| Basal Cell Carcinoma | Usually lowest concern when superficial and fully treated | Complete removal, recurrence, pathology, follow-up | Favorable classes can be possible |
| Squamous Cell Carcinoma | Usually manageable when superficial and fully treated; more concern if aggressive or metastatic | Depth, site, recurrence, immune status, treatment, follow-up | Favorable to rated depending on details |
| Melanoma In Situ | More serious than common nonmelanoma skin cancers, but confined to epidermis | Pathology, complete excision, recurrence, surveillance | Carrier-specific favorable consideration may be possible |
| Invasive Melanoma | Highest concern of these common skin cancers | Breslow depth, ulceration, stage, nodes, metastasis, recurrence, time since treatment | Standard, rated, flat extra, postponement, or decline depending on case |
Life Insurance After Basal Cell Carcinoma
Basal cell carcinoma is often the most straightforward skin-cancer history for life insurance underwriting when the lesion was superficial, completely removed, and follow-up is favorable.
Banner’s current underwriting material specifically states that Preferred Plus may be considered for basal cell skin cancer when superficial. Other carriers may treat the same history differently, but this confirms that an automatic Standard-only assumption is too conservative.
Life Insurance After Squamous Cell Carcinoma
Superficial squamous cell carcinoma can also receive favorable underwriting after successful treatment. Banner’s current underwriting guide says Preferred Plus may be considered for superficial squamous cell skin cancer.
SCC deserves more individualized review than routine BCC because certain cases can grow rapidly or spread. Underwriters may pay closer attention to lesion location, depth, recurrence, immune suppression, lymph-node findings, treatment, and whether all disease was removed.
Life Insurance After Melanoma
Melanoma is the skin-cancer history that usually requires the most detailed underwriting review. Current American Cancer Society staging guidance highlights the same core factors life underwriters care about: Breslow tumor thickness, ulceration, lymph-node involvement, distant metastasis, and overall stage.
The Skin Cancer Foundation estimates approximately 234,680 melanoma diagnoses in the U.S. in 2026, including 122,680 in situ and 112,000 invasive cases. That distinction matters medically and for underwriting.
Melanoma In Situ and Life Insurance
Melanoma in situ is stage 0 melanoma. It is confined to the epidermis and has not grown into deeper layers, nearby lymph nodes, or distant sites.
This is generally a more favorable underwriting profile than invasive melanoma, but the exact offer remains carrier-specific. Underwriters may want the pathology report, treatment date, margin status, dermatology follow-up, and confirmation that there has been no recurrence or invasive melanoma elsewhere.
What Medical Records Do Life Insurance Underwriters Need?
The pathology report is usually the most valuable document because it answers the questions that drive the risk assessment.
Diagnosis
BCC, SCC, melanoma in situ, invasive melanoma, or another skin tumor.
Pathology Details
Breslow depth, ulceration, margins, subtype, and other reported features.
Stage / Spread
TNM stage, lymph-node findings, sentinel node biopsy if performed, and any evidence of metastasis.
Treatment
Excision, Mohs surgery, lymph-node procedure, immunotherapy, targeted therapy, radiation, or other treatment.
Dates
Date diagnosed, date treatment ended, and dates of follow-up examinations.
Recurrence
Any recurrent melanoma, additional primary melanomas, repeated BCC/SCC lesions, or new concerning findings.
An attending physician statement (APS) or dermatology records may be requested when the carrier needs more detail. A traditional medical exam is not automatically required in every skin-cancer case.
How Melanoma Stage and Breslow Depth Affect Underwriting
| Medical Stage | Medical Description | Life Insurance Underwriting Focus |
|---|---|---|
| Stage 0 | Melanoma in situ, confined to epidermis | Complete treatment, pathology, margins, follow-up, recurrence |
| Stage I | Localized invasive melanoma, generally no nodal or distant spread | Breslow depth, ulceration, treatment, surveillance, time since treatment |
| Stage II | Deeper localized melanoma without nodal or distant spread | Greater recurrence concern; depth, ulceration, treatment, elapsed time |
| Stage III | Regional lymph-node and/or nearby skin/lymphatic spread | Node involvement, systemic treatment, recurrence risk, disease-free interval |
| Stage IV | Distant metastatic disease | Active disease status, treatment, response, recurrence, long-term stability |
The American Cancer Society notes that melanomas under 1 mm thick have a relatively small chance of spreading, while risk generally rises as thickness increases. Ulceration also worsens prognosis.
What Life Insurance Rating Can You Get After Skin Cancer?
There is no responsible way to promise one rate class from the diagnosis alone. Depending on the carrier and complete case, possible outcomes include:
- Preferred or Preferred Plus consideration — possible with some superficial BCC/SCC histories and selected favorable cases
- Standard or Standard Plus
- Table rating
- Temporary flat extra
- Postponement
- Decline
Can You Get Term Life Insurance After Skin Cancer?
Yes. Term life insurance is often available after successfully treated BCC, SCC, melanoma in situ, and selected invasive melanoma histories. The rate and timing depend on underwriting.
If you need substantial income-replacement or mortgage protection, compare term life insurance first. If the need is permanent, compare guaranteed universal life as well.
Can You Get No-Exam Life Insurance After Skin Cancer?
Possibly. “No exam” does not mean “no underwriting.” Accelerated underwriting programs can still use medical records, prescription data, electronic health information, prior insurance data, and other permitted sources.
See our no-exam life insurance guide.
Which Life Insurance Companies Are Good for Skin Cancer History?
The strongest carrier depends on the exact diagnosis. Current Banner underwriting material explicitly allows Preferred Plus consideration for superficial BCC and superficial SCC. For melanoma, carrier comparison becomes much more individualized.
Companies such as Banner, Protective, Prudential, Corebridge, Principal, and others may treat the same pathology differently based on depth, stage, time since treatment, and follow-up.
That is why high-risk life insurance underwriting expertise matters more than chasing the lowest online quote.
The best carrier is the carrier that fits your actual skin-cancer history—not the company with the cheapest advertisement.
People Also Ask About Life Insurance After Skin Cancer
Can you get life insurance after basal cell carcinoma?
Yes. A superficial BCC that was completely treated can be a favorable life insurance case. Some carriers may consider preferred classes, depending on pathology, recurrence, follow-up, and the rest of the health profile.
Can you get life insurance after squamous cell carcinoma?
Yes. Superficial, completely treated SCC can qualify for favorable rates with selected insurers. Deeper, recurrent, aggressive, or metastatic SCC requires more cautious underwriting.
Can you get life insurance after melanoma?
Yes, in many cases. The offer depends on stage, Breslow depth, ulceration, lymph-node involvement, treatment, recurrence, and time since treatment.
Can melanoma in situ qualify for Preferred life insurance?
Possibly with selected carriers, but it should not be promised. Melanoma in situ is stage 0 and is more favorable than invasive melanoma, but the insurer still reviews pathology, complete treatment, margins, follow-up, recurrence, and the overall health profile.
Do I need to wait after skin cancer before applying?
Not always. Some fully treated BCC and superficial SCC cases can be considered without a lengthy delay. Melanoma may require a disease-free interval depending on stage, pathology, treatment, and carrier guidelines.
Will a life insurance company require my pathology report?
It is common for melanoma underwriting and more complex skin-cancer histories. The pathology report provides the depth, ulceration, margins, subtype, and other details needed to assess risk.
Life Insurance After Skin Cancer FAQ
Does having skin cancer automatically mean higher life insurance rates?
No. Some superficial BCC and SCC histories can still receive preferred consideration. Melanoma and more aggressive or recurrent cancers are more likely to affect pricing.
Is recurrence an automatic decline?
No universal rule applies. Recurrence increases underwriting concern, especially with melanoma, but the result depends on the type of cancer, stage, treatment, timing, and carrier.
Can I get permanent life insurance after skin cancer?
Potentially. Term, GUL, and other permanent products can all be considered depending on underwriting.
What should I gather before requesting a life insurance review?
Diagnosis, pathology report, stage, Breslow depth if melanoma, treatment dates, margin status, lymph-node results if applicable, recurrence history, medications, and most recent dermatology follow-up.
Should I apply to several carriers at the same time?
Usually no. It is often better to pre-screen the case first, identify the strongest carrier, and then submit a formal application.
Bottom Line: Skin Cancer Does Not Automatically Block Life Insurance
A superficial basal cell carcinoma may have little effect on the final offer, while invasive melanoma can require detailed pathology review and a more conservative carrier strategy.
The best carrier is the carrier that fits your health profile—not the carrier with the cheapest advertisement. Shop first. Apply second.
Start with a ballpark quote, complete the health assessment, call us, or schedule a conversation. Final eligibility, rate class, and pricing are determined by the issuing insurer.
Sources & Review Method
Reviewed October 2026 for 2027 planning. Medical staging and skin-cancer facts were checked against current American Cancer Society and Skin Cancer Foundation materials. Underwriting examples were checked against current public carrier underwriting material where available. Life insurance decisions remain carrier-specific and depend on the complete medical record.
